The results provide the list of clinically relevant endpoints which will be used for monitoring the treatment and assess efficacy individually.
Most of the studies measure the efficacy of the specific treatment through surrogate endpoints and not through clinically relevant endpoints.
The results of this study supply the health professionals a help to start and assess clinical studies that assesses the efficacy of the specific treatment in patients with AFD.